Effects of Direct Oral Anticoagulants on Quality of Life During Periprocedural Management for Dental Extractions

2019 ◽  
Vol 77 (5) ◽  
pp. 904-911 ◽  
Author(s):  
Fatih Cabbar ◽  
Ayça Turer Cabbar ◽  
Kahraman Coşansu ◽  
Elif İjlal Çekirdekçi
Keyword(s):  
Quality Of Life ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Periprocedural Management

Quality of life of elderly people on oral anticoagulant for atrial fibrillation: VKA versus direct oral anticoagulants

2015 ◽  
Vol 13 (1) ◽  
pp. 45-54 ◽  
Author(s):  
Sarah Fareau ◽  
Karine Baumstarck ◽  
Anaïs Farcet ◽  
Catherine Molines ◽  
Pascal Auquier ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Atrial Fibrillation ◽  
Elderly People ◽  
Oral Anticoagulant ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants

scholarly journals Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life

TH Open ◽  
2021 ◽  
Vol 05 (02) ◽  
pp. e200-e210
Author(s):  
Paolo Zappulla ◽  
Valeria Calvi
Keyword(s):  
Quality Of Life ◽  
Gastrointestinal Bleeding ◽  
Current Knowledge ◽  
Oral Anticoagulant Therapy ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Anticoagulation Therapy ◽  
Current Evidence ◽  
Increased Risk

AbstractA significant problem for patients undergoing oral anticoagulation therapy is gastrointestinal bleeding (GIB), a problem that has become increasingly urgent following the introduction of direct oral anticoagulants (DOACs). Furthermore, in recent years a greater focus has been placed on the quality of life (QOL) of patients on long-term oral anticoagulant therapy, which necessitates changes in lifestyle, as well as posing an increased risk of bleeding without producing objective symptomatic relief. Here, we examine current evidence linked to GIB associated with oral anticoagulants, with a focus on randomized control trials, meta-analyses, and postmarketing observational studies. Rivaroxaban and dabigatran (especially the 150-mg bis-in-die dose) appeared to be linked to an increased risk of GIB. The risk of GIB was also greater when edoxaban was used, although this was dependent on the dose. Apixaban did not pose a higher risk of GIB in comparison with warfarin. We provided a summary of current knowledge regarding GIB risk factors for individual anticoagulants, prevention strategies that lower the risk of GIB and management of DOAC therapy after a GIB episode.

Periprocedural Management of Direct Oral Anticoagulants

2016 ◽  
Vol 41 (2) ◽  
pp. 127-129 ◽  
Author(s):  
James D. Douketis ◽  
Summer Syed ◽  
Sam Schulman
Keyword(s):  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Periprocedural Management

scholarly journals Atrial fibrillation, oral anticoagulants and health related quality of life

Cor et Vasa ◽  
2018 ◽  
Vol 60 (6) ◽  
pp. e597-e602 ◽  
Author(s):  
Ketija Apsite ◽  
Baiba Lurina ◽  
Andris Tupahins ◽  
Vladimirs Voicehovskis ◽  
Tarass Ivascenko ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Atrial Fibrillation ◽  
Oral Anticoagulants ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related
Sign in / Sign up

Export Citation Format

Share Document